Ophthotech ( NASDAQ : OPTH ) got crushed 85 % in today's trade , after it announced that its key drug Fovista failed in phase 3 trials on wet AMD ...
... the stock plummeted from $US 39 , down to $US 5 + change ...
Market Cap smashed from $US 1500 million , to $US 200 m. : Ouch !
... next cab off the rank , step right up to stage : Opthea !
Well , I guess the failure of Fovista puts more of a spotlight on our product ...
... a lesson for wannabe investors : Bio-techs are not for the faint hearted ..
really really good, page-5
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $467.8M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 39.0¢ | 37.5¢ | $176.6K | 463.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 121324 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 90033 | 3 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| OPT (ASX) Chart |